Viewing StudyNCT00248560



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00248560
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2005-11-03

Brief Title: Gemcitabine and Docetaxel in Treating Patients With Persistent Recurrent or Metastatic Head and Neck Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization: Barbara Ann Karmanos Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
recurrent squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
metastatic squamous neck cancer with occult primary squamous cell carcinoma View
recurrent metastatic squamous neck cancer with occult primary View
recurrent squamous cell carcinoma of the nasopharynx View
stage IV squamous cell carcinoma of the nasopharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity View